-
Signature
-
/s/ Daniel J. Groman, Attorney-in-fact
-
Stock symbol
-
WD
-
Transactions as of
-
Jan 9, 2024
-
Transactions value $
-
-$1,625,370
-
Form type
-
4
-
Date filed
-
1/10/2024, 05:30 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
WD |
Common Stock |
Options Exercise |
$334K |
+20K |
+10.44% |
$16.72* |
212K |
Jan 9, 2024 |
Direct |
|
transaction |
WD |
Common Stock |
Sale |
-$774K |
-7.96K |
-3.76% |
$97.23 |
204K |
Jan 9, 2024 |
Direct |
F1, F2 |
transaction |
WD |
Common Stock |
Sale |
-$1.19M |
-12K |
-5.92% |
$98.49 |
192K |
Jan 9, 2024 |
Direct |
F1, F3 |
holding |
WD |
Common Stock |
|
|
|
|
|
252K |
Jan 9, 2024 |
By HIII 2011 Trust |
|
holding |
WD |
Common Stock |
|
|
|
|
|
4.76K |
Jan 9, 2024 |
By ESS 2022 Trust |
|
holding |
WD |
Common Stock |
|
|
|
|
|
4.76K |
Jan 9, 2024 |
By ADS 2015 Trust |
|
holding |
WD |
Common Stock |
|
|
|
|
|
4.76K |
Jan 9, 2024 |
By MHS 2010 Trust |
|
holding |
WD |
Common Stock |
|
|
|
|
|
4.56K |
Jan 9, 2024 |
By HWS IV 2012 Trust |
|
holding |
WD |
Common Stock |
|
|
|
|
|
4.42K |
Jan 9, 2024 |
By MMAS 2008 Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
WD |
Common Stock |
Options Exercise |
$0 |
-20K |
-33.24% |
$0.00 |
40.2K |
Jan 9, 2024 |
Common Stock |
20K |
$16.72 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: